Hypothyroidism-induced Reversible Encephalopathy as a Cause of Aggravation of Parkinsonism and Myoclonus in Parkinson’s Disease by Ehm, Gwanhee et al.
Case Reports
Hypothyroidism-induced Reversible Encephalopathy as a Cause of Aggravation







1 Department of Neurology, National Medical Center, Seoul, Korea, 2 Department of Neurology, College of Medicine, Seoul National University, Seoul, Korea,
3 Movement Disorder Center, Seoul National University Hospital, Seoul, Korea, 4 Parkinson Study Group, Neuroscience Research Institute,
College of Medicine, Seoul National University, Seoul, Korea
Abstract
Background: Myoclonus and encephalopathy are unusual in patients with Parkinson’s disease (PD).
Case report: We describe the case of a 59-year-old male with PD who developed myoclonus and encephalopathy. Underlying hypothyroidism was revealed after
admission and treated with levothyroxine. Myoclonus and encephalopathy were completely resolved following thyroid hormone replacement.
Discussion: Hypothyroidism can cause reversible myoclonus and encephalopathy along with unusual aggravation of parkinsonism symptoms in patients with PD.
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Introduction
Myoclonus is an unusual phenomenon in patients with Parkinson’s
disease (PD), especially non-demented patients. The development of
myoclonus in the course of PD may herald alternative diagnoses such
as corticobasal syndrome.1 However, since myoclonus may be due to
other medical conditions, a diagnosis other than neurodegenerative
disease should be considered. Herein, we describe a patient with PD who
had hypothyroidism presenting as abrupt development of myoclonus.
Case report
A 59-year-old male patient previously diagnosed with PD at age 48
was admitted for encephalopathy, severe exacerbation of parkinson-
ism, and myoclonus. He had been treated with levodopa and had an
excellent response for the first 5 or 6 years of the disease. He under-
went bilateral subthalamic nucleus deep brain stimulation surgery
(DBS) at age 54 years because of severe dyskinesia and motor
fluctuation despite meticulous medication adjustment. Following DBS,
his parkinsonism was alleviated, and he could engage in socially active work.
One month before admission, he had a delusion that a spy was
watching him and visual hallucinations developed. His caregiver
reported that the patient slept for almost 20 hours a day. His articu-
lation deteriorated to the point where his family could hardly under-
stand his words. He became unable to walk without assistance. His
caregiver continued to regularly administer the antiparkinsonian drugs
to prevent further symptom aggravation. Although the patient con-
tinued taking his usual PD medication, his condition worsened. On
admission, generalized bradykinesia and rigidity were severely aggra-
vated. Remarkably, myoclonus was present in all four extremities. The
myoclonus appeared while maintaining posture and during action and
was more prominent in both distal upper extremities, involving the
shoulders. The mainly positive myoclonus was not stimulus sensitive.
Electrophysiologic studies were not conducted. The results of thyroid
function testing included in the routine admission blood work-up
revealed an undetectable free thyroxine level and an elevated thyroid-
stimulating hormone level of 200.6 mIU/mL (normal: 0.4-4.1 mIU/mL).
Further investigation into the patient’s medical history revealed
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that he underwent total thyroidectomy for papillary thyroid cancer at
age 56 and had been treated with levothyroxine at another hospital.
However, he had accidentally stopped taking levothyroxine for about
2 months before the current admission. Based on his medical history and
laboratory test results, levothyroxine therapy was restarted immediately.
After supplementation, his parkinsonism, psychosis, sleep-related prob-
lems, emotional lability, and myoclonus markedly improved. By hospital
day 10, his general condition stabilized to his previous disease status.
Discussion
Our patient showed rapid deterioration of psychotic, emotional,
sleep-related, and motor symptoms over a few weeks, which is
uncommon and may not be explained by exacerbation of PD itself.
Myoclonus is also unusual in patients with PD. The prompt and
dramatic improvement following levothyroxine administration further
suggests hypothyroidism as the cause of this patient’s rapid, global
deterioration.
There is limited information on patients with aggravated parkinson-
ism due to hypothyroidism2,3 or hyperthyroidism.4,5 The accompanied
encephalopathy and myoclonus, which were reversed by levothyroxine
therapy, have not yet been reported in patients with PD and hypo-
thyroidism. This lack of literature may be partly due to a low level of
suspicion because the symptoms aggravated by hypothyroidism can be
masked by and misconstrued as deterioration of PD itself.
Based on this didactic case and as pointed out by other authors,2–4
thyroid function assessment should not be overlooked in patients with
PD who experience rapid aggravation of parkinsonism, encephalo-
pathy, and myoclonus. Since hypothyroidism can be managed with
appropriate medication, it should be included in the list of differential
diagnoses of unusual aggravation of parkinsonism and symptoms that
are not typical for PD, especially when the patient has underlying
thyroid disease.
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